ECX — Epigenomics AG Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Epigenomics AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	17.1	10.9	4.47	23	10.1
Net Total Accounts Receivable
Net Total Receivables	0.362	0.473	0.401	0.173	0.354
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	18.3	12.1	5.47	23.7	10.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.701	1.53	1.18	0.891	2.06
Net Intangible Assets
Other Long Term Assets
Total Assets	21.8	14	6.8	24.7	15.9
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.17	3.62	2.44	2.14	5.07
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.21	4.36	2.93	2.54	5.68
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	18.6	9.63	3.86	22.1	10.2
Total Liabilities & Shareholders' Equity	21.8	14	6.8	24.7	15.9
Total Common Shares Outstanding